Work

S3-4: ER Downregulation with Fulvestrant in Combination with pan-PI3K Inhibitor BKM120 Synergizes Against ER+/PI3K-Mutant Breast Cancer Xenografts In Vivo.

Year: 2011

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs11-s3-4

Authors: TW Miller, EM Fox, JM Balko, IM Meszoely, ME Sanders, MG Kuba, N Wagle, LA Garraway, S-M Maira, CL Arteaga

Institutions: Novartis (Switzerland), Vanderbilt University, Dana-Farber Cancer Institute, Novartis Institutes for BioMedical Research

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1975685996

FWCI:

Cites:

Cited by:

Related to: 10